Dr. Curtis Lee Harlow, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-557-4000 Fax: 719-542-7019 |
Danny C Ballenger, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-557-4000 Fax: 719-542-7019 |
Dean Q Volk, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1619 N Greenwood St, Suite 103, Pueblo, CO 81003 Phone: 719-542-2167 Fax: 719-542-0320 |
News Archive
Scientists at VIB and KU Leuven have shown that blocking the PHD1 oxygen sensor hinders the activation of p53, a transcription factor that aids colorectal cancer (CRC) cells in repairing themselves and thus resisting chemotherapy. Chemotherapy resistance remains a major clinical issue in the treatment of CRC. These findings indicate that PHD1 inhibition may have valuable therapeutic potential. The study was published in the leading medical journal EMBO Molecular Medicine, which features molecular biology-driven research.
Many think of social networks in terms of Facebook friends and Twitter followers, but for recent University of Georgia doctoral graduate Julie Rushmore, social networks are tools in the fight against infectious diseases.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has submitted to the U.S. Food & Drug Administration a New Drug Application (NDA) seeking approval to market low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms associated with menopause.
News-Medical spoke to Marvin Berman, Ph.D., the Founder and President of Quietmind Foundation, about neurofeedback therapy and its potential to develop and improve future treatments for neurogenerative disorders.
› Verified 7 days ago